Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen
<p>Abstract</p> <p>Background</p> <p>Rhabdoid Tumors (RTs) are highly aggressive pediatric malignancies with poor prognosis. There are currently no standard or effective treatments for RTs in part because treatments are not designed to specifically target these tumors....
Main Authors: | Mani Sridhar, Mathur Deepti, Zhang Zhikai, Smith Melissa E, Cimica Velasco, Kalpana Ganjam V |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/634 |
Similar Items
-
In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines
by: Das Bhaskar C, et al.
Published: (2011-09-01) -
The Pharmacological Implications of Flavopiridol: An Updated Overview
by: Hemant Joshi, et al.
Published: (2023-11-01) -
Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.
by: Wenjun Ni, et al.
Published: (2010-11-01) -
Complex effects of flavopiridol on the expression of primary response genes
by: Keskin Havva, et al.
Published: (2012-03-01) -
Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
by: Zi’ang Hu, et al.
Published: (2018-05-01)